• 1
    Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22:432438.MEDLINE
  • 2
    Miller WJ, Baron RL, Dodd GD, Federle MP. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1994; 193:645650.MEDLINE
  • 3
    Chen H-L, Chang M-H, Ni Y-H, Hsu H-Y, Lee P-I, Lee C-Y, Chen D-S. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996; 276:906908.MEDLINE
  • 4
    Chang M-H, Chen C-J, Lai M-S, Hsu H-M, Wu T-C, Kong M-S, Liang D-C, et al. , and the childhood hepatoma study group. Universal hepatitis B vaccination in Taiwan and incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336:18551859.MEDLINE
  • 5
    Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346:10511055.MEDLINE
  • 6
    Mazzella G, Accogli E, Sottili S, Kesti D, Orsini M, Salzetta A, Novelli V, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996; 24:141147.MEDLINE
  • 7
    Jacobson LP, Zhang B-C, Zhu Y-R, Wang J-B, Wu Y, Zhang Q-N, Yu L-Y, et al. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. Cancer Epidemiol Biomarkers Prev 1997; 6:257265.MEDLINE
  • 8
    Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996; 334:15611567.MEDLINE